Search Results
Found 1 results
510(k) Data Aggregation
(267 days)
AVIEW Lung Nodule CAD is a Computer-Aided Detection (CAD) software designed to assist radiologists in the detection of pulmonary nodules (with diameter 3-20 mm) during the review of CT examinations of the chest for asymptomatic populations. AVIEW Lung Nodule CAD provides adjunctive information to alert the radiologists to regions of interest with suspected lung nodules that may otherwise be overlooked. AVIEW Lung Nodule CAD may be used as a second reader after the radiologist has completed their initial read. The algorithm has been validated using non-contrast CT images, the majority of which were acquired on Siemens SOMATOM CT series scanners; therefore, limiting device use to use with Siemens SOMATOM CT series is recommended.
The AVIEW Lung Nodule CAD is a software product that detects nodules in the lung. The lung nodule detection model was trained by Deep Convolution Network (CNN) based algorithm from the chest CT image. Automatic detection of lung nodules of 3 to 20mm in chest CT images. By complying with DICOM standards, this product can be linked with the Picture Archiving and Communication System (PACS) and provides a separate user interface to provide functions such as analyzing, identifying, storing, and transmitting quantified values related to lung nodules. The CAD's results could be displayed after the user's first read, and the user could select or de-select the mark provided by the CAD. The device's performance was validated with SIEMENS’ SOMATOM series manufacturing. The device is intended to be used with a cleared AVIEW platform.
Here's a breakdown of the acceptance criteria and study details for the AVIEW Lung Nodule CAD, as derived from the provided document:
Acceptance Criteria and Reported Device Performance
Criteria (Standalone Performance) | Acceptance Criteria | Reported Device Performance |
---|---|---|
Sensitivity (patient level) | > 0.8 | 0.907 (0.846-0.95) |
Sensitivity (nodule level) | > 0.8 | Not explicitly stated as separate from patient level, but overall sensitivity is 0.907. |
Specificity | > 0.6 | 0.704 (0.622-0.778) |
ROC AUC | > 0.8 | 0.961 (0.939-0.983) |
Sensitivity at FP/scan 0.8 | 0.889 (0.849-0.93) at FP/scan=0.504 |
Study Details
1. Acceptance Criteria and Reported Device Performance (as above)
2. Sample size used for the test set and data provenance:
- Test Set Size: 282 cases (140 cases with nodule data and 142 cases without nodule data) for the standalone study.
- Data Provenance:
* Geographically distinct US clinical sites.
* All datasets were built with images from the U.S.
* Anonymized medical data was purchased.
* Included both incidental and screening populations.
* For the Multi-Reader Multi-Case (MRMC) study, the dataset consisted of 151 Chest CTs (103 negative controls and 48 cases with one or more lung nodules).
3. Number of experts used to establish the ground truth for the test set and their qualifications:
- Number of Experts: Three (for both the MRMC study and likely for the standalone ground truth, given the consistency in expert involvement).
- Qualifications: Dedicated chest radiologists with at least ten years of experience.
4. Adjudication method for the test set:
- Not explicitly stated for the "standalone study" ground truth establishment.
- For the MRMC study, the three dedicated chest radiologists "determined the ground truth" in a blinded fashion. This implies a consensus or majority vote, but the exact method (e.g., 2+1, 3+1) is not specified. It does state "All lung nodules were segmented in 3D" which implies detailed individual expert review before ground truth finalization.
5. Multi-Reader Multi-Case (MRMC) comparative effectiveness study:
- Yes, an MRMC study was performed.
- Effect size of human readers improving with AI vs. without AI assistance:
* AUC: The point estimate difference was 0.19 (from 0.73 unassisted to 0.92 aided).
* Sensitivity: The point estimate difference was 0.23 (from 0.68 unassisted to 0.91 aided).
* FP/scan: The point estimate difference was 0.24 (from 0.48 unassisted to 0.28 aided), indicating a reduction in false positives. - Reading Time: "Reading time was decreased when AVIEW Lung Nodule CAD aided radiologists."
6. Standalone (algorithm only without human-in-the-loop performance) study:
- Yes, a standalone study was performed.
- The acceptance criteria and reported performance for this study are detailed in the table above.
7. Type of ground truth used:
- Expert consensus by three dedicated chest radiologists with at least ten years of experience. For the standalone study, it is directly compared against "ground truth," which is established by these experts. For the MRMC study, the experts "determined the ground truth." The phrase "All lung nodules were segmented in 3D" suggests a thorough and detailed ground truth establishment.
8. Sample size for the training set:
- Not explicitly stated in the provided text. The document mentions the lung nodule detection model was "trained by Deep Convolution Network (CNN) based algorithm from the chest CT image," but does not provide details on the training set size.
9. How the ground truth for the training set was established:
- Not explicitly stated in the provided text.
Ask a specific question about this device
Page 1 of 1